# Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

> **NCT06782399** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Oliver Jonas** · enrollment: 25 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of the Skin
- Squamous Cell Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Microdevice

## Key facts

- **NCT ID:** NCT06782399
- **Lead sponsor:** Oliver Jonas
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-01
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782399, "Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06782399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*